{2-[7-(2-Methanesulfonyl-vinyl)-1H-indol-3-yl)-1,1-dimethyl-ethyl}-carbamic acid tert-butyl ester → {2-[7-(2-methanesulfonyl-ethyl)-1H-indol-3-yl]-1,1-dimethyl-ethyl}-carbamic acid tert-butyl ester
反応式
[C:1]([O:5][C:6](=[O:27])[NH:7][C:8]([CH3:26])([CH3:25])[CH2:9][C:10]1[C:18]2[C:13](=[C:14]([CH:19]=[CH:20][S:21]([CH3:24])(=[O:23])=[O:22])[CH:15]=[CH:16][CH:17]=2)[NH:12][CH:11]=1)([CH3:4])([CH3:3])[CH3:2]>CO.[Pd]>[C:1]([O:5][C:6](=[O:27])[NH:7][C:8]([CH3:26])([CH3:25])[CH2:9][C:10]1[C:18]2[C:13](=[C:14]([CH2:19][CH2:20][S:21]([CH3:24])(=[O:23])=[O:22])[CH:15]=[CH:16][CH:17]=2)[NH:12][CH:11]=1)([CH3:3])([CH3:4])[CH3:2]参加物
4
実験手順
To a solution of {2-[7-(2-methanesulfonyl-vinyl)-1H-indol-3-yl]-1,1-dimethyl-ethyl}-carbamic acid tert-butyl ester (0.40 g, 1.02,mmol) in methanol (20.0 mL) is added 10% Pd/C (0.10 g) in methanol (2.0 mL). The reaction mixture is purged with hydrogen and hydrogenation is carried out with a hydrogen balloon overnight. The reaction mixture is filtered and the filtrate is evaporated to dryness to give 320 mg of {2-[7-(2-methanesulfonyl-ethyl)-1H-indol-3-yl]-1,1-dimethyl-ethyl}-carbamic acid tert-butyl ester (80%). FDMS m/e=395.2 (M++1).
後処理
- customThe reaction mixture is purged with hydrogen and hydrogenation
- customis carried out with a hydrogen balloon overnight
- filtrationThe reaction mixture is filtered
- customthe filtrate is evaporated to dryness
出典と根拠
- ORDレコード
- ord-2b811ded5cc54bc39f20d5cd39b68575
- 出典データセット
- uspto-grants-2006_08
- 特許番号
- US07087635B2
反応ノート
読み込み中…